Abstract

In the last decade, carbon quantum dots (CQDs), as a novel class of carbon-based nanomaterials, have received increasing attention due to their distinct properties. CQDs are ultimately small nanoparticles with an average size below 10 nm, possessing high water solubility, alluring photoluminescence, photostability, excellent biocompatibility, low/none toxicity, environmental friendliness, and high sustainability, etc. In history, there are intermittent threats from viruses to humans, animals and plants worldwide, resulting in enormous crises and impacts on our life, environment, economy and society. Some recent studies have unveiled that certain types of CQDs exhibited high and potent antiviral activities against various viruses such as human coronavirus, arterivirus, norovirus and herpesvirus. Moreover, they have been successfully explored and developed for different virus detections including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This article exclusively overviews and discusses the recent progress of designing, synthesizing, modifying/functionalizing and developing CQDs towards effective virus detection as well as the inhibition and treatment of viral infection. Their mechanisms and applications against various pathogenic viruses are addressed. The latest outcomes for combating the coronavirus disease 2019 (COVID-19) utilizing CQDs are also highlighted. It can be envisaged that CQDs could further benefit the development of virus detectors and antiviral agents with added broad-spectrum activity and cost-effective production.

Details

Title
Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection
Author
Xue Yuxiang 1 ; Liu, Chenchen 2 ; Andrews, Gavin 3 ; Wang, Jinyan 4 ; Ge, Yi 3   VIAFID ORCID Logo 

 University of Edinburgh, Institute for Bioengineering, School of Engineering, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
 Imperial College London, Department of Metabolism, Digestion and Reproductive, Faculty of Medicine, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 Queen’s University Belfast, School of Pharmacy, Belfast, UK (GRID:grid.4777.3) (ISNI:0000 0004 0374 7521) 
 China Medical University, College of Basic Medical Science, Shenyang, China (GRID:grid.412449.e) (ISNI:0000 0000 9678 1884) 
Publication year
2022
Publication date
Dec 2022
Publisher
Springer Nature B.V.
e-ISSN
21965404
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2646394050
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.